New Drug Approvals

New drug approvals news from Drugs.com. Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

FDA Approves Vtama (tapinarof) Cream for the Treatment of Plaque Psoriasis in Adults

May 23 2022

LONG BEACH, Calif., and BASEL, Switzerland, May 24, 2022 — Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that the U.S. Food and Drug...

FDA Approves Dupixent (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis

May 20 2022

Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of FDA's Priority Review action date Dupixent 300 mg weekly significantly improved signs and...

New Drug Approvals

FDA Approves Vtama (tapinarof) Cream for the Treatment of Plaque Psoriasis in Adults

FDA Approves Dupixent (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX (tecovirimat)

FDA Approves Mounjaro (tirzepatide) Injection for the Treatment of Adults with Type 2 Diabetes

FDA Approves Radicava ORS (edaravone) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

FDA Approves Olumiant (baricitinib) Treatment for COVID-19 in Certain Hospitalized Adults